Free Trial
NYSE:ARCH

Arch Biopartners (ARCH) Stock Price, News & Analysis

Arch Biopartners logo
$134.83 0.00 (0.00%)
As of 01/14/2025

About Arch Biopartners Stock (NYSE:ARCH)

Key Stats

Today's Range
$134.83
$134.83
50-Day Range
N/A
52-Week Range
$116.44
$180.65
Volume
N/A
Average Volume
364,924 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARCH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arch Biopartners and its competitors with MarketBeat's FREE daily newsletter.

ARCH Stock News Headlines

See More Headlines

ARCH Stock Analysis - Frequently Asked Questions

Arch Biopartners' stock was trading at $134.83 at the beginning of the year. Since then, ARCH shares have increased by 0.0% and is now trading at $134.83.
View the best growth stocks for 2025 here
.

Arch Biopartners' top institutional shareholders include Total Clarity Wealth Management Inc..

Shares of ARCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arch Biopartners investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Adobe (ADBE), CrowdStrike (CRWD) and Palo Alto Networks (PANW).

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:ARCH
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
N/A
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NYSE:ARCH) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners